A statistical experimental design approach to evaluate the influence of various penetration enhancers on transdermal drug delivery of buprenorphine

Journal of Advanced Research
S Mojtaba TaghizadehFatemeh Mohamadnia

Abstract

A series of drug-in-adhesive transdermal drug delivery systems (patch) with different chemical penetration enhancers were designed to deliver drug through the skin as a site of application. The objective of our effort was to study the influence of various chemical penetration enhancers on skin permeation rate and adhesion properties of a transdermal drug delivery system using Box-Behnken experimental design. The response surface methodology based on a three-level, three-variable Box-Behnken design was used to evaluate the interactive effects on dependent variables including, the rate of skin permeation and adhesion properties, namely peel strength and tack value. Levulinic acid, lauryl alcohol, and Tween 80 were used as penetration enhancers (patch formulations, containing 0-8% of each chemical penetration enhancer). Buprenorphine was used as a model penetrant drug. The results showed that incorporation of 20% chemical penetration enhancer into the mixture led to maximum skin permeation flux of buprenorphine from abdominal rat skin while the adhesion properties decreased. Also that skin flux in presence of levulinic acid (1.594 μg/cm(2) h) was higher than Tween 80 (1.473 μg/cm(2) h) and lauryl alcohol (0.843 μg/cm(2) h), and in...Continue Reading

References

Aug 1, 1977·British Journal of Pharmacology·A CowanI R Macfarlane
Sep 29, 2001·International Journal of Pharmaceutics·J ShokriM Barzegar Jalali
Feb 21, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Amit Kumar JainRamesh Panchagnula
Nov 14, 2002·International Journal of Pharmaceutics·N Kanikkannan, Mandip Singh
Jan 16, 2003·International Journal of Pharmaceutics·A NokhodchiM Barzegar-Jalali
Jul 13, 2005·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Mellar P Davis
Nov 25, 2005·Current Drug Delivery·Heather A E Benson
Dec 27, 2005·Bioorganic & Medicinal Chemistry·Tomás HolasAlexandr Hrabálek
Jun 15, 2007·Pain Practice : the Official Journal of World Institute of Pain·Enno FreyeJoseph Victor Levy
Aug 9, 2007·Analytica Chimica Acta·S L C FerreiraW N L dos Santos
Sep 2, 2008·Talanta·Marcos Almeida BezerraLuciane Amélia Escaleira
Jun 13, 2009·Recent Patents on Drug Delivery & Formulation·Abdus SamadMohammad Shabaz Shams
Apr 3, 2010·Archives of Pharmacal Research·Robhash Kusam SubediHoo-Kyun Choi
Dec 16, 2011·Journal of Advanced Pharmaceutical Technology & Research·Reshmy RajanDeepa T Vasudevan

❮ Previous
Next ❯

Citations

Sep 1, 2015·Acta Anaesthesiologica Taiwanica : Official Journal of the Taiwan Society of Anesthesiologists·Jing-Yang LiouChien-Kun Ting
Jun 14, 2020·International Journal of Molecular Sciences·Lamya H Al-WahaibiGamal A Shazly
Aug 13, 2020·Dose-response : a Publication of International Hormesis Society·Tahani S BasahihOsama A A Ahmed

❮ Previous
Next ❯

Software Mentioned

Expert
Design

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.